Co-Micronization: Innovative Technology to Enhance Oral Bioavailability of Poorly Soluble API’s
Posted on April 21, 2016
By: Jérôme Hecq, Pharm. D., Ph.D., Pharmaceutical R&D Manager
BERTIN PHARMA
Bordeaux, FRANCE
Summary Oral delivery is the most widely-used route of administration of active pharmaceutical ingredients as it is both more convenient for patients and cost effective from a production standpoint. However, in order to be available upon oral administration and exercise its pharmacological activity,...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
active pharmaceutical ingredients, BCS, Bertin Pharm, biopharmaceutical classification system, chemical entities, Co-Micronization, combinatorial chemistry, cost effective, dissolution, gastrointestinal tract, higher lipophilicity, higher molecular weight, Jérôme Hecq, membrane permeability, micronized drug, oral biovailability, Pharmaceutical Excipients, physicochemical properties, poorly soluble APIs, rate enhancement, solubility properties, surface properties
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
